ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,393Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 487

$474K Total Retail Price of All Prescriptions

Rank: 42 out of 487

514 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 514 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 514 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 6,936 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
SIMVASTATIN 510 392 1 4
LISINOPRIL 473 362 2 5
HYDROCODONE-ACETAMINOPHEN 435 221 S3 3 3
METFORMIN HCL 435 334 3 8
LEVOTHYROXINE SODIUM 432 368 5 1
AMLODIPINE BESYLATE 264 223 6 6
OMEPRAZOLE 229 158 7 2
HYDROCHLOROTHIAZIDE 219 168 8 9
ZOLPIDEM TARTRATE 185 156 9 14
CITALOPRAM HBR 176 149 10 12
ATORVASTATIN CALCIUM 162 121 11 18
WARFARIN SODIUM 153 143 12 11
TRAMADOL HCL 149 43 13 19
METOPROLOL TARTRATE 141 129 14 17
FUROSEMIDE 121 106 15 7
GLIPIZIDE 119 118 16 84
SERTRALINE HCL 118 75 17 21
LANTUS SOLOSTAR 117 66 18 72
ALENDRONATE SODIUM 105 85 19 27
METOPROLOL SUCCINATE 104 95 20 15
GABAPENTIN 102 73 21 13
CARISOPRODOL 94 0 R 22 76
AZITHROMYCIN 86 69 23 50
ADVAIR DISKUS 85 81 24 46
POTASSIUM CHLORIDE 82 70 25 10
CYCLOBENZAPRINE HCL 80 21 R 26 64
PROAIR HFA 79 58 27 40
TAMSULOSIN HCL 77 75 28 25
ATENOLOL 74 70 29 23
SPIRIVA 74 50 29 48
ACETAMINOPHEN-CODEINE 73 58 S3 31 177
ALLOPURINOL 70 53 32 29
FLUTICASONE PROPIONATE 63 49 33 33
LOVASTATIN 63 62 33 30
TRAZODONE HCL 61 42 35 22
CARVEDILOL 56 49 36 32
DONEPEZIL HCL 56 56 36 38
PRAVASTATIN SODIUM 53 37 38 20
PREDNISONE 52 47 39 37
MELOXICAM 51 46 40 26
CYMBALTA 50 26 41 34
FLUOXETINE HCL 50 29 41 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.